EP1814595
Meðhöndlun krabbameins með blöndu af efni sem truflar EGF boðleiðina og fákirni sem minnkar clusterin þéttni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.11.2005EP published:
8.1.2014EP application number:
05810600.6
EP translation filed:
28.3.2014Grant published:
15.4.2014EPO information:
European Patent Register
Max expiry date:
21.11.2025Expiry date:
21.11.2017
Title:
TREATMENT OF CANCER WITH A COMBINATION OF AN AGENT THAT PERTURBS THE EGF SIGNALING PATHWAY AND AN OLIGONUCLEOTIDE THAT REDUCES CLUSTERIN LEVELS
Timeline
Today
22.11.2005EP application
8.1.2014EP Publication
28.3.2014Translation submitted
15.4.2014Registration published
21.11.2017Expires
Owner
Name:
THE UNIVERSITY OF BRITISH COLUMBIAAddress:
No 103 - 6190 Agronomy Road, Vancouver,British Columbia V6T 1Z3, CA
Inventor
Name:
GLEAVE, MartinAddress:
Vancouver, British Columbia V6R 1E8, CA
Name:
ZUPI, GabriellaAddress:
Roma, IT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
522948 PDate:
23.11.2004Country:
US
Number:
522960 PDate:
24.11.2004Country:
US
Classification
Categories:
A61K 48/00, A61P 35/00, A61K 39/395, A61K 31/7088
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 21.10.2014
Expires: 21.11.2015
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 2.11.2015
Expires: 21.11.2016
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 1.11.2016
Expires: 21.11.2017
Payer: Sigurjónsson & Thor ehf.